Although the 2017 and the latest 2022 WHO classifications of PA have abandoned Ki-67 index as a grading criterion, Ki-67 index of >3% is still an indispensable prognostic marker in the assessment of tumor aggressiveness (3, 5, 60). Here, MKI67 is linked to neoplasm.